Ceftobiprole versus ceftriaxone ± linezolid in Community-Acquired Bacterial Pneumonia (CABP): Re-analysis of a randomized, phase 3 study using 2020 FDA guidance. - Shorr, Andrew F.; Jones, Mark E.; Friedmann, Silke; Ionescu, Daniel; Saulay, Mikael; Smart, Jennifer I.; Engelhardt, Marc (PLoS ONE, 2025)